Detalhe da pesquisa
1.
The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host disease.
Ann Hematol
; 102(9): 2529-2542, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37490114
2.
Extracorporeal portosystemic shunt in secondary Budd-Chiari syndrome.
J Hepatol
; 73(4): 974-976, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32684366
3.
FLA-IDA salvage chemotherapy combined with a seven-day course of venetoclax (FLAVIDA) in patients with relapsed/refractory acute leukaemia.
Br J Haematol
; 188(3): e11-e15, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31681986
4.
Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis.
Front Oncol
; 12: 867356, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36059667
5.
A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy.
Leukemia
; 35(6): 1763-1772, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33082512
6.
Gains of REL in primary mediastinal B-cell lymphoma coincide with nuclear accumulation of REL protein.
Genes Chromosomes Cancer
; 46(4): 406-15, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17243160